Latest News and Press Releases

MINNEAPOLIS, July 30, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the Canaccord Genuity Growth Conference in Boston...

Revenue increased 22% to $37.6 million, exceeding the top end of guidanceAdjusted EPS increased 38% to $0.29, exceeding the top end of guidance; GAAP EPS of $0.21Raising 2015 revenue guidance to...

MINNEAPOLIS, June 30, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its second quarter conference call on Tuesday, July 21 at...

Now offering three versions of Turnpike catheters for use in complex coronary and peripheral interventionsTurnpike Spiral features an outer coil on the distal shaft for added rotational advancement...

MINNEAPOLIS, April 29, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the Bank of America Merrill Lynch 2015 Health...

- Revenue increased 16% to $34.6 million, exceeding the top end of guidance - Adjusted EPS, excluding expenses associated with the Short Kit litigation, increased 18% to $0.21, exceeding the top...

MINNEAPOLIS, March 31, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its first quarter conference call on Tuesday, April 21 at...

MINNEAPOLIS, March 16, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has commenced sales of the PolarCath peripheral dilatation system in the United States in...

- Q4 net revenue increased 15.5% to a record quarterly level of $33.6 million, exceeding the top end of guidance - Q4 GAAP EPS increased 15% to $0.23, exceeding the top end of guidance - 2015...

- Signs agreement to acquire 26,000-square-foot building adjacent to existing manufacturing facility for $2.7 million - Will house company's component manufacturing operations and freeze-dried...